Canada markets closed

AstraZeneca PLC (AZNCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
155.26-0.46 (-0.30%)
At close: 02:10PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close155.72
Open157.05
Bid0.00 x 0
Ask0.00 x 0
Day's Range152.28 - 157.05
52 Week Range118.16 - 159.12
Volume921
Avg. Volume3,509
Market Cap240.69B
Beta (5Y Monthly)0.16
PE Ratio (TTM)38.34
EPS (TTM)4.05
Earnings DateJul 25, 2024
Forward Dividend & Yield2.86 (1.84%)
Ex-Dividend DateFeb 22, 2024
1y Target EstN/A
  • Reuters

    PRESS DIGEST-British Business - May 14

    The following are the top stories on the business pages of British newspapers. - Anglo American rejected a raised takeover offer of 34 billion pounds ($42.67 billion) from BHP Group on Monday, saying the world's largest listed miner "continues to significantly undervalue" the company. - JPMorgan Chase has pledged a further 40 million pounds ($50.22 million) in philanthropic investments in the UK over five years in a sign of its increasing focus on Britain.

  • The Telegraph

    UK pharma giants pledge £430m investment in France after Macron charm offensive

    Britain’s two biggest pharmaceutical companies have pledged £430m of investment in France after a charm offensive by Emmanuel Macron.

  • Zacks

    Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study

    Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails to meet the primary endpoint of progression-free survival in unresectable stage III NSCLC.